Correlation Between Revolution Medicines and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Revolution Medicines and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Revolution Medicines and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Mineralys Therapeutics,.

Diversification Opportunities for Revolution Medicines and Mineralys Therapeutics,

0.38

Correlation Coefficient

Revolution Medicines  Mineralys Therapeutics,

Weak diversification

The 3 months correlation between Revolution and Mineralys is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between Revolution Medicines and Mineralys Therapeutics,

Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.94 times more return on investment than Mineralys Therapeutics,. However, Revolution Medicines is 1.06 times less risky than Mineralys Therapeutics,. It trades about 0.0 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest  3,858  in Revolution Medicines on April 24, 2025 and sell it today you would lose (105.00) from holding Revolution Medicines or give up 2.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Revolution Medicines  vs.  Mineralys Therapeutics, Common

Revolution Medicines

Risk-Adjusted Performance

Very Weak

Over the last 90 days Revolution Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Revolution Medicines is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Mineralys Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Revolution Medicines and Mineralys Therapeutics,

The main advantage of trading using opposite Revolution Medicines and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind Revolution Medicines and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..